BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng M, Li T, Li Y, Zhang T, Zhang L, Ma W, Zhou L. Survival Profile and Prognostic Factors for Appendiceal Mixed Neuroendocrine Non-neuroendocrine Neoplasms: A SEER Population-Based Study. Front Oncol 2020;10:1660. [PMID: 32903647 DOI: 10.3389/fonc.2020.01660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Palmer K, Weerasuriya S, Chandrakumaran K, Rous B, White BE, Paisey S, Srirajaskanthan R, Ramage JK. Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry. Front Oncol 2022;12:915028. [DOI: 10.3389/fonc.2022.915028] [Reference Citation Analysis]
2 Holmager P, Langer SW, Kjaer A, Ringholm L, Garbyal RS, Pommergaard HC, Hansen CP, Federspiel B, Andreassen M, Knigge U. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Curr Treat Options Oncol 2022. [PMID: 35362798 DOI: 10.1007/s11864-022-00969-x] [Reference Citation Analysis]
3 Elpek GO. Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update. World J Gastroenterol 2022; 28(8): 794-810 [DOI: 10.3748/wjg.v28.i8.794] [Reference Citation Analysis]
4 Wang G, Li Q, Chen W. Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study. BMC Cancer 2021;21:778. [PMID: 34225672 DOI: 10.1186/s12885-021-08502-3] [Reference Citation Analysis]
5 Hoehn RS, Rieser CJ, Choudry MH, Melnitchouk N, Hechtman J, Bahary N. Current Management of Appendiceal Neoplasms. Am Soc Clin Oncol Educ Book 2021;41:1-15. [PMID: 33770459 DOI: 10.1200/EDBK_321009] [Reference Citation Analysis]